• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁-肝脏表型:探索胆管癌胆汁和肿瘤内的微生物群落景观

Bile-Liver phenotype: Exploring the microbiota landscape in bile and intratumor of cholangiocarcinoma.

作者信息

Wang Lei, Zhao Hui, Wu Fan, Chen Jiale, Xu Hanjie, Gong Wanwan, Wen Sijia, Yang Mengmeng, Xia Jiazeng, Chen Yu, Chen Daozhen

机构信息

Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi 214002, China.

Department of Hepatopancreatobiliary Surgery, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi 214002, China.

出版信息

Comput Struct Biotechnol J. 2025 Mar 18;27:1173-1186. doi: 10.1016/j.csbj.2025.03.030. eCollection 2025.

DOI:10.1016/j.csbj.2025.03.030
PMID:40206347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11981758/
Abstract

Cholangiocarcinoma (CCA) arises within the peritumoral bile microenvironment, yet microbial translocation from bile to intracholangiocarcinoma (IntraCCA) tissues remains poorly understood. Previous studies on bile microbiota alterations from biliary benign disease (BBD) to CCA have yielded inconsistent results, highlighting the need for cross-study analysis. We presented a comprehensive analysis of five cohorts (N = 266), including our newly established 16S rRNA gene profiling (n = 42), to elucidate these microbiota transitions. The concordance of bacteria between CCA bile and intraCCA tissue, represented by Enterococcus and Staphylococcus, suggested microbiota migration from bile to intratumoral tissues. A computational random forest machine learning model effectively distinguished intraCCA tissue from CCA bile, identifying Rhodococcus and Ralstonia as diagnostically significant. The model also excelled in differentiating CCA bile from BBD bile, achieving an AUC value of 0.931 in external validation. Using unsupervised hierarchical clustering, we established Biletypes based on microbial signatures in our cohort. A combination of 17 genera effectively stratified patients into Biletype A and Biletype B. Biletype B robustly discerned CCA from BBD, with Sub-Biletype B1 correlating with advanced TNM stage and poorer prognosis. Among the 17 genera, bacterial Cluster 1, composed of Sphingomonas, Staphylococcus, Massilia, Paenibacillus, Porphyrobacter, Lawsonella, and Aerococcus, was enriched in Biletype B1 and predicted CCA with an AUC of 0.96. Staphylococcus emerged as a promising single-genus predictor for CCA diagnosis and staging. In conclusion, this study delineates a potential microbiota transition pathway from the gut through CCA bile to intra-CCA tissue, proposing Biletypes and Staphylococcus as biomarkers for CCA prognosis.

摘要

胆管癌(CCA)起源于肿瘤周围的胆汁微环境,但从胆汁到胆管内癌(IntraCCA)组织的微生物易位仍知之甚少。先前关于从胆道良性疾病(BBD)到CCA的胆汁微生物群改变的研究结果并不一致,这凸显了进行跨研究分析的必要性。我们对五个队列(N = 266)进行了全面分析,包括我们新建立的16S rRNA基因谱分析(n = 42),以阐明这些微生物群的转变。以肠球菌和葡萄球菌为代表的CCA胆汁和IntraCCA组织之间细菌的一致性表明微生物群从胆汁迁移到肿瘤内组织。一个计算随机森林机器学习模型有效地将IntraCCA组织与CCA胆汁区分开来,确定红球菌和罗尔斯通氏菌具有诊断意义。该模型在区分CCA胆汁和BBD胆汁方面也表现出色,在外部验证中AUC值达到0.931。使用无监督层次聚类,我们根据队列中的微生物特征建立了胆汁类型。17个属的组合有效地将患者分为胆汁类型A和胆汁类型B。胆汁类型B能有力地将CCA与BBD区分开来,亚胆汁类型B1与晚期TNM分期和较差的预后相关。在这17个属中,由鞘氨醇单胞菌、葡萄球菌、马赛菌、芽孢杆菌、卟啉杆菌、劳森菌和气球菌组成的细菌簇1在胆汁类型B1中富集,预测CCA的AUC为0.96。葡萄球菌成为CCA诊断和分期的一个有前景的单属预测指标。总之,本研究描绘了一条从肠道经CCA胆汁到Intra-CCA组织的潜在微生物群转变途径,提出胆汁类型和葡萄球菌作为CCA预后的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/ddb90fd5b0cc/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/54cfb62c80a8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/b4a96db9ddb0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/f16fd2ae3c58/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/adfd0a78a1ef/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/0f561bef57bf/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/df6449dd31c9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/ddb90fd5b0cc/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/54cfb62c80a8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/b4a96db9ddb0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/f16fd2ae3c58/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/adfd0a78a1ef/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/0f561bef57bf/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/df6449dd31c9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41a/11981758/ddb90fd5b0cc/gr6.jpg

相似文献

1
Bile-Liver phenotype: Exploring the microbiota landscape in bile and intratumor of cholangiocarcinoma.胆汁-肝脏表型:探索胆管癌胆汁和肿瘤内的微生物群落景观
Comput Struct Biotechnol J. 2025 Mar 18;27:1173-1186. doi: 10.1016/j.csbj.2025.03.030. eCollection 2025.
2
Dysbiosis of Bile Microbiota in Cholangiocarcinoma Patients: A Comparison with Benign Biliary Diseases.胆管癌患者胆汁微生物群失调:与良性胆道疾病的比较
Int J Mol Sci. 2025 Feb 13;26(4):1577. doi: 10.3390/ijms26041577.
3
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma.基于肠道微生物组的预测模型可提高胆管癌患者的诊断效果。
Front Cell Infect Microbiol. 2021 Nov 23;11:751795. doi: 10.3389/fcimb.2021.751795. eCollection 2021.
4
Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.胆汁来源的循环细胞外 miR-30d-5p 和 miR-92a-3p 作为胆管癌的潜在生物标志物。
Hepatobiliary Pancreat Dis Int. 2020 Feb;19(1):41-50. doi: 10.1016/j.hbpd.2019.10.009. Epub 2019 Nov 8.
5
A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients.一种新型双歧杆菌/克雷伯氏菌比值在 CCA 患者肠道和胆汁微生物群特征分析中的应用。
Microb Ecol. 2023 Nov 30;87(1):5. doi: 10.1007/s00248-023-02318-3.
6
Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.肝外胆管癌胆道微生物群失调的特征。
PLoS One. 2021 Mar 9;16(3):e0247798. doi: 10.1371/journal.pone.0247798. eCollection 2021.
7
Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.分析血浆胆汁酸谱以区分胆管癌与良性胆道疾病和健康对照。
J Steroid Biochem Mol Biol. 2021 Jan;205:105775. doi: 10.1016/j.jsbmb.2020.105775. Epub 2020 Oct 28.
8
Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients.胆汁微生物组分析鉴定胆总管结石和胆管癌患者之间的区域微生物群。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):233-240. doi: 10.31557/APJCP.2021.22.1.233.
9
Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.血清胆汁酸组成模式及血清甘氨胆酸水平在胆管癌中的诊断价值
Oncol Lett. 2017 Oct;14(4):4943-4948. doi: 10.3892/ol.2017.6763. Epub 2017 Aug 17.
10
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma.促炎胆道微生物群在原发性硬化性胆管炎和胆管癌中的潜在作用
Cancers (Basel). 2022 Apr 24;14(9):2120. doi: 10.3390/cancers14092120.

本文引用的文献

1
Evaluating stool microbiome integrity after domestic freezer storage using whole-metagenome sequencing, genome assembly, and antimicrobial resistance gene analysis.使用全基因组测序、基因组组装和抗菌药物耐药基因分析评估家用冰箱储存后粪便微生物群的完整性。
Microbiol Spectr. 2025 Mar 4;13(3):e0227824. doi: 10.1128/spectrum.02278-24. Epub 2025 Feb 11.
2
lefser: implementation of metagenomic biomarker discovery tool, LEfSe, in R.lefser:宏基因组生物标志物发现工具LEfSe在R语言中的实现
Bioinformatics. 2024 Nov 28;40(12). doi: 10.1093/bioinformatics/btae707.
3
The updated Asia-Pacific consensus statement on the role of endoscopic management in malignant hilar biliary obstruction.
关于内镜治疗在恶性肝门部胆管梗阻中作用的亚太地区共识声明更新版。
Endosc Int Open. 2024 Sep 16;12(9):E1065-E1074. doi: 10.1055/a-2366-7302. eCollection 2024 Sep.
4
Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis.利用现有的 16S rRNA 基因调查来破译宫颈癌变中的微生物特征和失调。
Sci Rep. 2024 May 21;14(1):11532. doi: 10.1038/s41598-024-62531-z.
5
Identification and validation of microbial biomarkers from cross-cohort datasets using xMarkerFinder.使用 xMarkerFinder 从跨队列数据集识别和验证微生物生物标志物。
Nat Protoc. 2024 Sep;19(9):2803-2830. doi: 10.1038/s41596-024-00999-9. Epub 2024 May 14.
6
Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.鉴定结直肠癌中 KRAS 突变相关的肠道微生物群,并构建预测性机器学习模型。
Microbiol Spectr. 2024 May 2;12(5):e0272023. doi: 10.1128/spectrum.02720-23. Epub 2024 Apr 4.
7
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.肿瘤微生物组的特征及其与肝内胆管癌预后的关系。
J Gastroenterol. 2024 May;59(5):411-423. doi: 10.1007/s00535-024-02090-2. Epub 2024 Mar 10.
8
Intratumoural microbiota: a new frontier in cancer development and therapy.肿瘤内微生物群:癌症发展和治疗的新前沿。
Signal Transduct Target Ther. 2024 Jan 10;9(1):15. doi: 10.1038/s41392-023-01693-0.
9
Characterization of immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancers.从金黄色葡萄球菌中鉴定免疫调节因子,用于三阴性乳腺癌的免疫原性治疗。
Sci Rep. 2024 Jan 8;14(1):756. doi: 10.1038/s41598-024-51361-8.
10
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.TOPAZ-1 研究的简明报告:度伐利尤单抗联合化疗治疗晚期胆道癌。
Future Oncol. 2023 Nov;19(34):2277-2289. doi: 10.2217/fon-2023-0468. Epub 2023 Sep 25.